{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:50:22Z","timestamp":1754153422971,"version":"3.41.2"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Long COVID, previously known as Post-Acute Sequelae of SARS-CoV-2 (PASC), refers to prolonged symptoms or diagnosable conditions following COVID-19 infection. The neuropsychiatric profile of Long COVID patients remains ambiguous. This study aimed to assess neuropsychiatric symptoms in a retrospective cohort of Long COVID patients (<jats:italic>N<\/jats:italic>\u202f=\u202f162) at a Rehabilitation Medicine clinic in South Texas. Clinical data from patient records were used to calculate a Symptom Score, and screening tools for stress\/PTSD (PCL-5), depression (PHQ-9), anxiety (GAD-7), and quality of life (SWL) were employed to evaluate if Long COVID duration and severity could predict neuropsychiatric outcomes. The majority were female (71%) and Hispanics (53%) who presented for treatment of Long COVID symptoms during the study period, including fatigue (93%), coughing\/shortness of breath (81%), fever (67%), anosmia (58%), ageusia (54%), and weight loss (56%). A minority of participants were hospitalized (<jats:italic>N<\/jats:italic>\u202f=\u202f49) or required ventilator support (<jats:italic>N<\/jats:italic>\u202f=\u202f5) during acute infection. There was a high burden of neuropsychiatric symptoms, including subjective cognitive impairment (79%), headache (74%), and insomnia (58%). Symptom Score (median\u202f=\u202f9, IQR [8,11]) was significantly correlated with increased depression (PHQ-9; <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05), anxiety (GAD-7; <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05) and elevated stress\/PTSD (PCL-5; <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05) symptoms. Long COVID patients taking stimulants or mood stabilizers had higher GAD-7 (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.031, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.035) and PHQ-9 (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.034, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.009) scores but not PCL-5 scores. Importantly, duration of Long COVID symptomatology also did not predict PCL-5 scores. No patient factors (e.g., sex, age, BMI, ethnicity) mediated Symptom Score. Nonetheless, historically marginalized groups, such as women and Hispanics, have been disproportionately affected by COVID-19. This study is the first to utilize validated screening tools to determine the presence and severity of neuropsychiatric symptoms in Long COVID patients. These findings may guide clinical management and future research on Long COVID, especially in historically excluded populations.<\/jats:p>","DOI":"10.3389\/fneur.2025.1612489","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:13:31Z","timestamp":1753244011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropsychiatric symptoms cluster as primary drivers of Long COVID complexity: a South Texas retrospective cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Anne Marie","family":"Wells","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summer","family":"Rolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Robles-Ramamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Gibson-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Goros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Gelfond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Gelfond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Balfanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"McGeary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Verduzco-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"year":"2023","key":"ref1"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41579-023-01001-1","article-title":"Clinical course and management of COVID-19 in the era of widespread population immunity","volume":"22","author":"Meyerowitz","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"ref3","article-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","volume-title":"StatPearls [Internet]","author":"Cascella","year":"2023"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2128568","DOI":"10.1001\/jamanetworkopen.2021.28568","article-title":"Short-term and long-term rates of Postacute sequelae of SARS-CoV-2 infection: a systematic review","volume":"4","author":"Groff","year":"2021","journal-title":"JAMA Netw Open [Internet]."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of Postacute sequelae of SARS-CoV-2 infection","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"volume-title":"A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. Goldowitz I, Worku T, Brown L, Fineberg HV, editors. Washington (DC): National Academies Press (US)","year":"2024","key":"ref6"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"104413","DOI":"10.1016\/j.ebiom.2022.104413","article-title":"Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes","volume":"87","author":"Reese","year":"2023","journal-title":"EBioMedicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11606-022-07908-4","article-title":"Symptom clusters seen in adult COVID-19 recovery clinic care seekers","volume":"38","author":"Danesh","year":"2023","journal-title":"J Gen Intern Med [Internet]"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","volume":"30","author":"Cai","year":"2024","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0254347","DOI":"10.1371\/journal.pone.0254347","article-title":"Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT","volume":"16","author":"Bell","year":"2021","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/bmj-2022-071050","article-title":"Post-acute sequelae of covid-19 six to 12 months after infection: population based study","volume":"379","author":"Peter","year":"2022","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2022.02.006","article-title":"The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2","volume":"45","author":"Bauer","year":"2022","journal-title":"Trends Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/ofid\/ofaf278","article-title":"Association of SARS-CoV-2 with health-related quality of life 1 year after illness using latent transition analysis","volume":"12","author":"Wisk","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1001\/jamahealthforum.2022.1809","article-title":"The costs of long COVID","volume":"3","author":"Cutler","year":"2022","journal-title":"JAMA Health Forum [Internet]"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12985-023-02061-8","article-title":"Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants","volume":"20","author":"Wang","year":"2023","journal-title":"Virol J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/heq.2021.0190","article-title":"Structural racism, place, and COVID-19: a narrative review describing how we prepare for an endemic COVID-19 future","volume":"6","author":"Estrada","year":"2022","journal-title":"Health Equity"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"103439","DOI":"10.1016\/j.jvb.2020.103439","article-title":"The impact of the COVID-19 pandemic on marginalized populations in the United States: a research agenda","volume":"119","author":"Kantamneni","year":"2020","journal-title":"J Vocat Behav"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1177\/10815589231190560","article-title":"Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital","volume":"71","author":"Munipalli","year":"2023","journal-title":"J Investig Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e2455430","DOI":"10.1001\/jamanetworkopen.2024.55430","article-title":"Sex differences in long COVID","volume":"8","author":"Shah","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1236702","DOI":"10.3389\/fmed.2023.1236702","article-title":"Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study","volume":"10","author":"N\u00fa\u00f1ez","year":"2023","journal-title":"Front Med (Lausanne)"},{"year":"2024","key":"ref23"},{"year":"2025","key":"ref24"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1430444","DOI":"10.3389\/fmed.2024.1430444","article-title":"Long COVID management: a mini review of current recommendations and underutilized modalities","volume":"11","author":"Dietz","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/v16050685","article-title":"Impact of prior COVID-19 immunization and\/or prior infection on immune responses and clinical outcomes","volume":"16","author":"Livieratos","year":"2024","journal-title":"Viruses."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/v16081222","article-title":"SARS-CoV-2 variants and clinical outcomes of special populations: a scoping review of the literature","volume":"16","author":"Livieratos","year":"2024","journal-title":"Viruses."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/v16111795","article-title":"Beyond antivirals: alternative therapies for long COVID","volume":"16","author":"Livieratos","year":"2024","journal-title":"Viruses"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e63656","DOI":"10.7759\/cureus.63656","article-title":"The prevalence and associated factors of post-COVID-19 fatigue: a systematic review and Meta-analysis","volume":"16","author":"Hu","year":"2024","journal-title":"Cureus"},{"year":"2022","key":"ref30"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.euroneuro.2022.03.003","article-title":"Psychiatric disorders in post-acute COVID-syndrome (PDPACS): recommendations for health care professionals","volume":"58","author":"Paez","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamapsychiatry.2023.1321","article-title":"Neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms","volume":"80","author":"Braga","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e2111417","DOI":"10.1001\/jamanetworkopen.2021.11417","article-title":"Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review","volume":"4","author":"Nasserie","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/cjn.2020.173","article-title":"Neurological and neuropsychiatric impacts of COVID-19 pandemic","volume":"48","author":"Roy","year":"2021","journal-title":"Can J Neurol Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2213-2600(21)00125-9","article-title":"Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses","volume":"9","author":"Song","year":"2021","journal-title":"Lancet Respir Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"100399","DOI":"10.1016\/j.bbih.2021.100399","article-title":"Neurological consequences of COVID-19 and brain related pathogenic mechanisms: a new challenge for neuroscience","volume":"19","author":"Sarubbo","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"102101","DOI":"10.1016\/j.jchemneu.2022.102101","article-title":"An overview of the neurological aspects in COVID-19 infection","volume":"122","author":"Singh","year":"2022","journal-title":"J Chem Neuroanat"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-024-02967-z","article-title":"Association of post-COVID phenotypic manifestations with new-onset psychiatric disease","volume":"14","author":"Coleman","year":"2024","journal-title":"Transl Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-32275-3","article-title":"Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI","volume":"13","author":"Aj\u010devi\u0107","year":"2023","journal-title":"Sci Rep"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbi.2024.04.015","article-title":"Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures","volume":"119","author":"Van Elzakker","year":"2024","journal-title":"Brain Behav Immun"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s00415-022-11047-5","article-title":"Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study","volume":"269","author":"Cecchetti","year":"2022","journal-title":"J Neurol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"593520","DOI":"10.3389\/fneur.2020.593520","article-title":"Insights into neuroimaging findings of patients with coronavirus disease 2019 presenting with neurological manifestations","volume":"11","author":"Chen","year":"2020","journal-title":"Front Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/brain\/awab435","article-title":"Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up","volume":"145","author":"Huang","year":"2022","journal-title":"Brain"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e2112131","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-A report for the GCS-neuro COVID consortium and the ENERGY consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw Open."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1002\/alz.14089","article-title":"Parallel electrophysiological abnormalities due to COVID-19 infection and to Alzheimer\u2019s disease and related dementia","volume":"20","author":"Jiang","year":"2024","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s44192-025-00189-3","article-title":"COVID-19 and cognitive impairment: a review of the emerging evidence","volume":"5","author":"Aderinto","year":"2025","journal-title":"Discover Mental Health"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.ensci.2023.100485","article-title":"Neurological complications after COVID-19: a narrative review","volume":"33","author":"Molaverdi","year":"2023","journal-title":"eNeurologicalSci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation","volume":"28","author":"Blevins","year":"2015","journal-title":"J Trauma Stress"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1037\/cps0000111","article-title":"The posttraumatic stress disorder (PTSD) checklist for DSM\u20135: a systematic review of existing psychometric evidence","volume":"30","author":"Forkus","year":"2023","journal-title":"Clin Psychol (New York)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/jamapsychiatry.2022.4092","article-title":"The heterogeneity of posttraumatic stress disorder in DSM-5","volume":"80","author":"Bryant","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1281012","DOI":"10.3389\/fpubh.2023.1281012","article-title":"Sleep quality among non-hospitalized COVID-19 survivors: a national cross-sectional study","volume":"11","author":"Hoang","year":"2023","journal-title":"Front Public Health"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/jcm13030839","article-title":"Sleep disturbances as a consequence of long COVID-19: insights from Actigraphy and Clinimetric examinations\u2014an uncontrolled prospective observational pilot study","volume":"13","author":"Ta\u0144ski","year":"2024","journal-title":"J Clin Med"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1016\/j.cub.2018.09.054","article-title":"Abnormal locus coeruleus activity during sleep alters sleep signatures of memory consolidation and impairs place cell stability and spatial memory","volume":"28","author":"Swift","year":"2018","journal-title":"Curr Biol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.psychres.2017.10.033","article-title":"Comparing global assessment of functioning (GAF) and World Health Organization disability assessment schedule (WHODAS) 2.0 in schizophrenia","volume":"259","author":"Gspandl","year":"2018","journal-title":"Psychiatry Res"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3233\/JAD-220397","article-title":"Mini-mental state examination and Montreal cognitive assessment as tools for following cognitive changes in Alzheimer\u2019s Disease Neuroimaging Initiative participants","volume":"90","author":"Wang","year":"2022","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s40001-023-01265-6","article-title":"Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer\u2019s disease and mild cognitive impairment: a retrospective analysis of the ADNI database","volume":"28","author":"Wang","year":"2023","journal-title":"Eur J Med Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.3390\/ijerph18136835","article-title":"Assessing cognitive abilities using the wais-iv: an item response theory approach","volume":"18","author":"Abdelhamid","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e01894","DOI":"10.1002\/brb3.1894","article-title":"Psychometric properties of structured clinical interview for DSM-5 disorders-clinician version (SCID-5-CV)","volume":"11","author":"Shabani","year":"2021","journal-title":"Brain Behav"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat Neurosci"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e0315486","DOI":"10.1371\/journal.pone.0315486","article-title":"Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: a pilot study","volume":"20","author":"Lawrence","year":"2025","journal-title":"PLoS One."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/arclin\/acac093","article-title":"Cognitive complaints assessment and neuropsychiatric disorders after mild COVID-19 infection","volume":"38","author":"Hammerle","year":"2023","journal-title":"Arch Clin Neuropsychol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.2147\/JMDH.S432969","article-title":"Cognitive dysfunction in hospitalized patient with moderate-to-severe COVID-19: a 1-year prospective observational study","volume":"16","author":"Vasile","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e0312530","DOI":"10.1371\/journal.pone.0312530","article-title":"Association between long COVID and nonsteroidal anti-inflammatory drug use by patients with acute-phase COVID-19: a nationwide Korea National Health Insurance Service cohort study","volume":"19","author":"Lee","year":"2024","journal-title":"PLoS One"},{"year":"2013","key":"ref65"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cpr.2010.06.012","article-title":"The diagnostic accuracy of the PTSD checklist: a critical review","volume":"30","author":"McDonald","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population","volume":"46","author":"L\u00f6we","year":"2008","journal-title":"Med Care"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1370\/afm.1139","article-title":"Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population","volume":"8","author":"Arroll","year":"2010","journal-title":"Ann Fam Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","article-title":"The satisfaction with life scale","volume":"49","author":"Diener","year":"1985","journal-title":"J Pers Assess"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1207\/s15327752jpa5701_17","article-title":"Further validation of the satisfaction with life scale: evidence for the cross-method convergence of well-being measures","volume":"57","author":"Pavot","year":"1991","journal-title":"J Pers Assess."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1612489\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:13:32Z","timestamp":1753244012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1612489\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":72,"alternative-id":["10.3389\/fneur.2025.1612489"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1612489","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"article-number":"1612489"}}